• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Mast Therapeutics, Inc. (MSTX)

    -NYSE MKT
    0.23 Down 0.19(44.59%) Feb 10, 4:00PM EST
    Prev Close:0.42
    Open:0.26
    Bid:0.22 x 10500
    Ask:0.26 x 10000
    1y Target Est:2.90
    Beta:-0.712225
    Earnings Date:Mar 22 - Mar 28 (Est.)
    Day's Range:0.21 - 0.27
    52wk Range:0.21 - 0.62
    Volume:14,395,047
    Avg Vol (3m):1,470,540
    Market Cap:37.72M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MSTX

    Comparison

    Symbol% ChgMkt Cap
    MSTXDown 44.59%37.72M
    GSKDown 0.53%94.69B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.25
    Quarterly EPS Est (Dec-15) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback